169 related articles for article (PubMed ID: 37935612)
1. Tumor-induced osteomalacia: An overview.
Jadhav SS; Shah R; Patil V
Best Pract Res Clin Endocrinol Metab; 2024 Mar; 38(2):101834. PubMed ID: 37935612
[TBL] [Abstract][Full Text] [Related]
2. Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A).
Houang M; Clarkson A; Sioson L; Elston MS; Clifton-Bligh RJ; Dray M; Ranchere-Vince D; Decouvelaere AV; de la Fouchardiere A; Gill AJ
Hum Pathol; 2013 Dec; 44(12):2711-8. PubMed ID: 24060005
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics of Malignant Phosphaturic Mesenchymal Tumor Causing Tumor-Induced Osteomalacia.
Abate V; Vergatti A; De Filippo G; Damiano V; Menale C; D'Elia L; Rendina D
J Clin Endocrinol Metab; 2024 Feb; 109(3):e1006-e1011. PubMed ID: 38006315
[TBL] [Abstract][Full Text] [Related]
4. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
[TBL] [Abstract][Full Text] [Related]
5. The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?
Ledford CK; Zelenski NA; Cardona DM; Brigman BE; Eward WC
Clin Orthop Relat Res; 2013 Nov; 471(11):3618-25. PubMed ID: 23868423
[TBL] [Abstract][Full Text] [Related]
6. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
Hu FK; Yuan F; Jiang CY; Lv DW; Mao BB; Zhang Q; Yuan ZQ; Wang Y
Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Induced Osteomalacia: an Up-to-Date Review.
Hautmann AH; Hautmann MG; Kölbl O; Herr W; Fleck M
Curr Rheumatol Rep; 2015 Jun; 17(6):512. PubMed ID: 25900190
[TBL] [Abstract][Full Text] [Related]
8. Phosphaturic mesenchymal tumor: A chondromyxoid fibroma-like type.
Koga K; Iwasaki H; Nabeshima K
J Dermatol; 2023 Nov; 50(11):1484-1487. PubMed ID: 37350024
[TBL] [Abstract][Full Text] [Related]
9. Tumour-induced Osteomalacia Secondary to Intracranial Tumours - Report of 2 Cases.
Gunawat PV; Shaikh ST; Deopujari CE
J Assoc Physicians India; 2019 Apr; 67(4):85-86. PubMed ID: 31299850
[TBL] [Abstract][Full Text] [Related]
10. Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature.
Woo VL; Landesberg R; Imel EA; Singer SR; Folpe AL; Econs MJ; Kim T; Harik LR; Jacobs TP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):925-32. PubMed ID: 19828339
[TBL] [Abstract][Full Text] [Related]
11. Tumor induced osteomalacia from a peripheral mesenchymal tumour of the foot.
Strydom A; Greeff W; Ferrao PNF; Saragas NP
Foot (Edinb); 2023 May; 55():101979. PubMed ID: 36871520
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic osteomalacia due to phosphaturic mesenchymal tumour in the upper thoracic spine.
Garg B; Mehta N; Goyal A; Khadgawat R
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33328210
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic and molecular features of six cases of phosphaturic mesenchymal tumor.
Sun L; Dehner C; Kenney J; McNulty SM; Zhu X; Pfeifer JD; Maluf HM; Chrisinger JSA
Virchows Arch; 2021 Apr; 478(4):757-765. PubMed ID: 33151412
[TBL] [Abstract][Full Text] [Related]
14. Clinical, morphological and immunohistochemical analysis of 13 cases of phosphaturic mesenchymal tumor - A holistic diagnostic approach.
Chatterjee D; Bardia A; Pal R; Saikia UN; Bhadada SK; Radotra BD
Ann Diagn Pathol; 2021 Oct; 54():151783. PubMed ID: 34329884
[TBL] [Abstract][Full Text] [Related]
15. Phosphaturic Mesenchymal Tumor.
Benson JC; Trejo-Lopez JA; Nassiri AM; Eschbacher K; Link MJ; Driscoll CL; Tiegs RD; Sfeir J; DeLone DR
AJNR Am J Neuroradiol; 2022 Jun; 43(6):817-822. PubMed ID: 35589138
[TBL] [Abstract][Full Text] [Related]
16. Phosphaturic Mesenchymal Tumors in the Head and Neck Demonstrate a Broad Clinical and Morphologic Spectrum.
Hulme KR; Mahar A; Campbell RG; Clifton-Bligh R; Gill AJ; Palme CE; Gupta R
Head Neck Pathol; 2022 Sep; 16(3):902-912. PubMed ID: 35119617
[TBL] [Abstract][Full Text] [Related]
17. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
[TBL] [Abstract][Full Text] [Related]
18. Phosphaturic mesenchymal tumour-mixed connective tissue variant without oncogenic osteomalacia.
Winters R; Bihlmeyer S; McCahill L; Cooper K
J Clin Pathol; 2009 Aug; 62(8):760-1. PubMed ID: 19638551
[TBL] [Abstract][Full Text] [Related]
19. A Phosphaturic Mesenchymal Tumor Presenting as Reversible Metabolic Myopathy.
Abdulla M
Saudi J Kidney Dis Transpl; 2023 Nov; 34(6):666-670. PubMed ID: 38725216
[TBL] [Abstract][Full Text] [Related]
20. Phosphaturic mesenchymal tumor: two cases highlighting differences in clinical and radiologic presentation.
Gu J; Ge C; Joshi G; Most M; Tai R
Skeletal Radiol; 2024 May; 53(5):995-1002. PubMed ID: 37792035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]